Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Becoming More Attractive for Investors

Roman Campbell

Teva- Pharmaceutical Industries Ltd. ADR’s filing revealed that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.37 million on Dec 16 ’25. In the deal valued at $30.20 per share,12,300 shares were sold. As a result of this transaction, Weiss Amir now holds 5,650 shares worth roughly $0.17 million.

Then, MIGNONE ROBERTO sold 77,400 shares, generating $2,340,646 in total proceeds. Upon selling the shares at $30.24, the Director now owns 367,600 shares.

Before that, Bridger Management, LLC (1) bought 150,000 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $4,527,000 were divested by the Shareholder at a price of $30.18 per share.

Barclays initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to an Overweight in a research note published on December 09, 2025; the price target was $35. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early December with a ‘”a Sector outperform”‘ rating. Goldman began covering TEVA with “Buy” recommendation on June 06, 2025. Truist started covering the stock on May 28, 2025. It rated TEVA as “a Buy”.

Price Performance Review of TEVA

On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock jump 0.10% to $30.35. Over the last five days, the stock has gained 1.88%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 45.35% since the year began. Nevertheless, the stocks have risen 37.70% over the past one year. While a 52-week high of $30.44 was reached on 12/19/25, a 52-week low of $12.47 was recorded on 04/10/25.

Levels Of Support And Resistance For TEVA Stock

The 24-hour chart illustrates a support level at 29.97, which if violated will result in even more drops to 29.59. On the upside, there is a resistance level at 30.65. A further resistance level may holdings at 30.94.

How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?

A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-11-28, dropping by -4.77 million shares to a total of 45.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 50.39 million shares. There was a decline of -10.46%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.